PharmAthene (PIP) Reports Q3 EPS of $1.67

PharmAthene (NYSE: PIP) reported Q3 EPS of $1.67, versus ($0.02) reported last year. Revenue for the quarter came in at $993 thousand, versus $1.16 million reported last year.

For earnings history and earnings-related data on PharmAthene (PIP) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• LSI Industries (LYTS) Tops Q4 EPS by 3c, Beats on Revenue